FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 93 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,498,000 | +2450.3% | 375,864 | +780.2% | 0.00% | – |
| Q2 2022 | $294,000 | -4.5% | 42,700 | +29.0% | 0.00% | – |
| Q1 2022 | $308,000 | -34.3% | 33,100 | +0.3% | 0.00% | – |
| Q4 2021 | $469,000 | -32.6% | 33,000 | +10.0% | 0.00% | – |
| Q3 2021 | $696,000 | -13.4% | 30,000 | -7.1% | 0.00% | – |
| Q2 2021 | $804,000 | +1.4% | 32,300 | +14.1% | 0.00% | – |
| Q1 2021 | $793,000 | -2.1% | 28,300 | +22.0% | 0.00% | – |
| Q4 2020 | $810,000 | -29.9% | 23,200 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $1,156,000 | – | 23,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |